Beta-2 Glycoprotein 1 (ß2GPI) Antibodies Report Format

Pathology
report-cta
Download Report Sample

Explore cutting-edge diagnostics. One click to preview your report sample.

What is the β2GPI Antibody Test?

The Beta-2 Glycoprotein 1 (β2GPI) antibody test detects autoantibodies directed against β2GPI, a protein involved in blood clotting. These antibodies are highly specific for Antiphospholipid Syndrome (APS) and are associated with thrombosis and pregnancy-related complications.

What is a β2GPI Antibodies Report Format?

A β2GPI report provides quantitative levels of IgG and/or IgM antibodies against β2GPI in the blood. It supports the diagnosis of APS when interpreted with clinical history and other laboratory findings.

Tests Included in β2GPI Antibodies Report

Test

Description

β2GPI IgG/IgM

Measures the concentration of IgG and/or IgM antibodies against beta-2 glycoprotein 1.

Key Parts of a β2GPI Antibodies Report

Key Part

Description

Antibody Class

Specifies whether IgG or IgM was tested.

Measured Value

Quantitative result expressed in standardized units (U/mL).

Reference Range

Categorizes the result as negative, equivocal, or positive.

Interpretation

Explains the relevance of the findings in clinical context.

Normal Range for β2GPI Antibodies Report

Result

Value (U/mL)

Negative

<20

Equivocal

20–39

Positive

≥40

Parameters to Consider in β2GPI Report

Parameter

Interpretation

Isotype (IgG vs IgM)

IgG is more strongly associated with clinical complications.

Persistent Positivity

Required (12 weeks apart) for APS diagnosis.

Association with aCL

Presence of both increases the likelihood of thrombotic events.

Clinical History

Important to correlate results with history of thrombosis or pregnancy loss.

Guidelines for β2GPI Antibodies Report Format

Guideline

Description

Unit Consistency

Report results in U/mL using validated lab standards.

Confirmatory Testing

Repeat after 12 weeks to confirm persistence.

Panel Integration

Often reported alongside aCL and lupus anticoagulant.

What Do the Results Mean?

Result Type

Interpretation

Negative

No significant β2GPI antibodies detected.

Equivocal

May require retesting for clarity.

Positive

Indicates increased risk for thrombosis or pregnancy complications—requires clinical follow-up.

β2GPI Antibodies Report Interpretation

Test

Interpretation

β2GPI IgG/IgM

Detects antiphospholipid antibodies specific to β2GPI, crucial for diagnosing Antiphospholipid Syndrome (APS). Persistent elevation confirms autoimmune risk.

report-cta
Effortless Lab Management Starts Here!

Experience the future of lab operations. One click to revolutionize your lab.

Structure of the DoraysLIS Report

pathology report

FAQ’s

We design our products in such a way that makes software purchase decisions for our customers more value based than traditional software companies.

pathology lab software

Yes. With DoraysLIS, you can customize the report templates with your logo, color scheme, fonts, address, header/footer content, and preferred layout to match your lab needs and company requirements.

Essential identifiers included in the report templates are:

  • Patient's unique identification number
  • Patient details
  • Lab registration number
  • Date and time of sample collection
  • Specimen type and quality
  • Date and time of report generation
  • Referral doctor’s details
  • Hospital/clinic information (if applicable)
  • Test method
  • normal range based on gender
  • Interpretation/contextual remarks/recommended action
  • Digital signature

Absolutely, DoraysLIS provides 140+ specialized templates for various departments, including pathology, biochemistry, hematology, radiology, and microbiology. There are also miscellaneous templates for uncategorized tests.

You can also assign different report templates to specific doctors, departments, or test types to maintain clarity and consistency.

Rest assured, our report formats are designed to comply with the Indian Council of Medical Research (ICMR) standards and guidelines.

DoraysLIS is a secure cloud-based lab management system. Therefore, all our reports go through several layers of protection, including:

  • HIPAA and Indian medical data protection guidelines compliance
  • Secure report access protocols
  • Patient data anonymization technology
  • QR Code integration
  • Digital signature and encryption
  • In-built restrictions on report sharing

As an advanced lab information management system, DoraysLIS Report Formats offer:

  • QR code/ barcode readability
  • Multiple language support
  • Compatibility with different systems
  • Mobile and web-based report viewing options
  • PDF and MS Word formats

Yes. You can instantly share reports via email, WhatsApp, or SMS directly from the LIS without manual intervention. This reduces time and effort.

Yes. DoraysLIS allows consolidated reporting where you can create summary reports for corporate clients, health camps, or group testing conditions.

Yes, all our reports will be securely saved in our dedicated cloud server. You can search, retrieve, download, and resend reports anytime from anywhere with your secure login credentials.

Trusted By 1100+ Businesses Globally

15M+ Patient Records
20k+ Doctors
40+ Cities
10+ Countries

Exciting Updates at DoraysLis

Discover the latest advancements, services, and features we're offering to enhance your experience at DoraysLis. We're constantly evolving to provide you with the best diagnostic services, cutting-edge technology, and expert care. Stay tuned for our new offerings and improvements that will make your visits more efficient and comprehensive.

Related Resources